Skip to main content
Erschienen in:

01.06.2019 | Case report

Ipilimumab/nivolumab

Various toxicities: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Fazel M, et al. Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma. Case Reports in Immunology 2019: 30 Apr 2019. Available from: URL: https://doi.org/10.1155/2019/2539493 - USA Fazel M, et al. Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma. Case Reports in Immunology 2019: 30 Apr 2019. Available from: URL: https://​doi.​org/​10.​1155/​2019/​2539493 - USA
Metadaten
Titel
Ipilimumab/nivolumab
Various toxicities: case report
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63751-1